# The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)

> **NCT00887315** · PHASE2 · TERMINATED · sponsor: **University of Chicago** · enrollment: 11 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Docetaxel and cisplatin
- **RADIATION:** Docetaxel and cisplatin Plus Hypofractionated Radiotherapy

## Key facts

- **NCT ID:** NCT00887315
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-06
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Slow accrual and loss of sponsor
- **Last updated:** 2013-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887315, "The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00887315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*